Copyright
©The Author(s) 2020.
World J Hepatol. Dec 27, 2020; 12(12): 1148-1157
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1148
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1148
Figure 1 Summary of clinical and molecular characteristics of molecular-based subtypes of intrahepatic cholangiocarcinoma.
CA 19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; FGFR2: Fibroblast growth factor receptor 2; HER2: Human epidermal growth factor receptor; IDH: Isocitrate dehydrogenase; IG: Intraductal growing; MF: Mass forming; PI: Periductal infiltrating.
- Citation: Ahn KS, Kang KJ. Molecular heterogeneity in intrahepatic cholangiocarcinoma. World J Hepatol 2020; 12(12): 1148-1157
- URL: https://www.wjgnet.com/1948-5182/full/v12/i12/1148.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i12.1148